DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Levemir (Insulin Detemir Subcutaneous) - Reports of Side Effects & Adverse Reactions

 


Nutrilib.com
A comprihensive source of nutritional information

This is an index of adverse event reports related to Levemir (Insulin Detemir Subcutaneous). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (613)
     Blood Glucose Increased (248)Injection Site Erythema (33)Injection Site Pain (28)more >>

Cases resulting in a serious event (133)
     Blood Glucose Increased (13)Vomiting (9)Injection Site Erythema (9)more >>

Cases resulting in death (10)
     Renal Failure Acute (5)Cardio-Respiratory Arrest (3)Hypersensitivity (2)more >>

Cases resulting in life threatening events (17)
     Blood Pressure Increased (3)Convulsion (3)Blood Glucose Increased (3)more >>

Cases resulting in hospitalization (53)
     Vomiting (8)Asthenia (5)Hypersensitivity (4)more >>

Cases resulting in disability (2)
     Retinopathy (1)Condition Aggravated (1)Pharmaceutical Product Complaint (1)

Cases resulting in other serious reactions (77)
     Injection Site Pain (8)Blood Glucose Increased (7)Injection Site Erythema (6)more >>

Below is a sample of adverse event reports reports related to Levemir (Insulin Detemir Subcutaneous). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a physician from United States on 2007-10-31

Patient:

Adverse reactions / side effects: Dyspnoea, Throat Tightness, Rash Pruritic

Adverse event resulted in: hospitalization

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 29 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a physician from Bulgaria on 2007-10-31

Patient: 29 year old female

Adverse reactions / side effects: Intentional Overdose

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)

Other drugs received by patient: Novorapid



Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-31

Patient: female

Adverse reactions / side effects: Injection Site Injury

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a physician from United Kingdom on 2007-10-31

Patient: female, weighing 51.0 kg (112.2 pounds)

Adverse reactions / side effects: Head Injury

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Levemir
    Dosage: 30 iu, qd
    Start date: 2005-10-17

Novorapid
    Dosage: 47 iu, qd
    Start date: 2005-10-17



Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a physician from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Urticaria

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 56 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 56 year old female

Adverse reactions / side effects: Blood Glucose Decreased, Blood Glucose Increased

Suspect drug(s):
Levemir
    Dosage: subcutaneous ; subcutaneous ; 13 iu, qd, subcutaneous
    Indication: Type 1 Diabetes Mellitus
    End date: 2007-09-10

Levemir
    Dosage: subcutaneous ; subcutaneous ; 13 iu, qd, subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2007-09-10
    End date: 2007-09-16

Levemir
    Dosage: subcutaneous ; subcutaneous ; 13 iu, qd, subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2007-09-17

Other drugs received by patient: Humalog / 00030501 / (Insulin)



Adverse event in 56 year old male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 56 year old male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 60 year old male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 60 year old male

Adverse reactions / side effects: Injection Site Erythema, Injection Site Rash, Hyperhidrosis, Asthenia, Tremor, Injection Site Pruritus

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)

Other drugs received by patient: Glucophage / 00082701 / (Metformin)



Adverse event in receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a physician from United States on 2007-10-30

Patient:

Adverse reactions / side effects: Injection Site Erythema, Injection Site Pain

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Injection Site Bruising

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 52 year old male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 52 year old male

Adverse reactions / side effects: Injection Site Haemorrhage

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-30

Patient: male

Adverse reactions / side effects: Injection Site Urticaria

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 75 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 75 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a physician from United States on 2007-10-30

Patient: female

Adverse reactions / side effects: Injection Site Rash

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 83 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 83 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 78 year old male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 78 year old male

Adverse reactions / side effects: Device Failure, Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)

Other drugs received by patient: Humalog



Adverse event in 63 year old male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 63 year old male

Adverse reactions / side effects: Back Pain, Abdominal Pain

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)

Other drugs received by patient: Byetta (Exenatide, Exenatide); Metformin HCL



Adverse event in 72 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 72 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 69 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 69 year old female

Adverse reactions / side effects: Weight Increased, Injection Site Bruising, Blood Glucose Increased

Suspect drug(s):
Levemir
    Dosage: 10 lu, qd, subcutaneous; 40 ie
    Indication: Insulin-Requiring Type II Diabetes Mellitus
    Start date: 2007-07-24
    End date: 2007-08-01

Levemir
    Dosage: 10 lu, qd, subcutaneous; 40 ie
    Indication: Insulin-Requiring Type II Diabetes Mellitus
    Start date: 2007-08-01



Adverse event in 38 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a physician from United States on 2007-10-30

Patient: 38 year old female

Adverse reactions / side effects: Injection Site Pain, Injection Site Rash

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 52 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 52 year old female

Adverse reactions / side effects: Incorrect Dose Administered, Blood Glucose Increased

Suspect drug(s):
Levemir
    Dosage: 6 iu, single, subcutaneous 60 iu, qd, subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2007-08-01
    End date: 2007-08-01

Levemir
    Dosage: 6 iu, single, subcutaneous 60 iu, qd, subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2007-08-01



Adverse event in 71 year old male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a individual with unspecified qualification from United States on 2007-10-30

Patient: 71 year old male

Adverse reactions / side effects: Aphthous Stomatitis

Suspect drug(s):
Levemir
    Dosage: 50 u, qd, subcutaneous
    Start date: 2006-12-01

Novolog
    Dosage: subcutaneous
    Indication: Type 1 Diabetes Mellitus
    Start date: 2006-12-01



Adverse event in 65 year old female receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 65 year old female

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)



Adverse event in 58 year old male receiving Levemir (Insulin Detemir Subcutaneous)

Reported by a consumer/non-health professional from United States on 2007-10-30

Patient: 58 year old male

Adverse reactions / side effects: Blood Glucose Increased

Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008